Tormere Analytics

>/

Overview Market News Stock Research Charts Portfolio Lab Options Lab Calculators Watchlist

Privacy Policy Terms of Service

RVNC: Insider Trading, Congress Trades & Research | Tormere

RVNC

download financials (.py)

RVNC

Market Cap

$381M

As of 2026-10-25

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

—

Insufficient price history

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Price / TTM revenue

P/B

—

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

8

recent articles

No Form 4 transactions on record.

Recent News

REVANCE THERAPEUTICS Earnings Preview: Recent $RVNC Insider Trading, Hedge Fund Activity, and More

Quiver Quantitative · 2025-03-02

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

marketscreener.com · 2025-02-03

Revance Therapeutics: The Takeover Saga Continues As Teoxane Enters The Fray (NASDAQ:RVNC)

Seeking Alpha · 2025-01-14

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

ChartMill · 2024-02-28

How Revance Therapeutics, The IBD 50's No. 1 Stock, Is Taking On 'Prestige' Medical Aesthetics

Investor's Business Daily · 2023-02-03

Revance Therapeutics (RVNC) Stock News

Stock Titan · 2020-10-17

Revance Therapeutics (RVNC) Stock Price, News & Analysis

MarketBeat · 2015-06-10

RVNC: Revance Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas

Stocktwits · 2015-05-15

Informational purposes only, not investment advice.

RVNC (RVNC)

tormere.com/research/RVNC · generated 2026-10-28

General Information

Price—

Change—

Market Cap$381M

SectorHealth Care

IndustryPharmaceuticals

Exchange—

Beta (raw, monthly vs SPY)—

Signals

Insider Velocity—

Congress Trades (90d)—

Short Volume—

Conviction Score—

Recent News

REVANCE THERAPEUTICS Earnings Preview: Recent $RVNC Insider Trading, Hedge Fund Activity, and More — Quiver Quantitative · 2025-03-02
Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline — marketscreener.com · 2025-02-03
Revance Therapeutics: The Takeover Saga Continues As Teoxane Enters The Fray (NASDAQ:RVNC) — Seeking Alpha · 2025-01-14
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. — ChartMill · 2024-02-28
How Revance Therapeutics, The IBD 50's No. 1 Stock, Is Taking On 'Prestige' Medical Aesthetics — Investor's Business Daily · 2023-02-03

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →